Concepedia

Paul V. Kaplita

PV

Statistics

Publications

22

Citations

986

H-Index

16

Active since

1982

Affiliations

Boehringer Ingelheim (United States)(Current)

Boehringer Ingelheim (Germany)

Sterling Research Group (United States)

Sterling Research Group

Boehringer Ingelheim (France)

Paul V. Kaplita is an author at Boehringer Ingelheim (United States) specializing in pharmacology, drug discovery, and pharmacy.

Publications per year

1982–2012

22

Publications

22

Identification of pharmacological inhibitors of the MEK5/ERK5 pathway

Revati J. Tatake, Margaret M. O’Neill, Charles A. Kennedy et al. · Biochemical and Biophysical Research Communications · 2008 · 158 citations

, , +9

γ-Aminobutyric acid action in guinea-pig ileal myenteric plexus

Paul V. Kaplita, Donald H. Waters, David J. Triggle · European Journal of Pharmacology · 1982 · 113 citations

, , +2

Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence

Alfred J. Kolb, Paul V. Kaplita, Dave J. Hayes et al. · Drug Discovery Today · 1998 · 79 citations

, , +14

Discovery of potent and selective PKC-θ inhibitors

Charles L. Cywin, Georg Dahmann, Anthony S. Prokopowicz et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 70 citations · Full text

, , +12

Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β:  Part I:  Hit-to-Lead Strategies

Tina M. Morwick, Angela Berry, Janice R. Brickwood et al. · Journal of Medicinal Chemistry · 2006 · 68 citations · Full text

, , +17

1–5 of 22